SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-19-012565
Filing Date
2019-12-09
Accepted
2019-12-09 21:21:47
Documents
2
Period of Report
2019-12-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1773
2 ex24mccamish.htm EX-24 8847
  Complete submission text file 0001179110-19-012565.txt   12113
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Issuer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FORTY SEVEN, INC. 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address
McCamish Mark Anthony (Reporting) CIK: 0001390798 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37977 | Film No.: 191276410